Search Results (564)

Background and Objective: Placenta Accreta Spectrum (PAS) encompasses a continuum of abnormal placentation conditions associated with significant maternal and fetal morbidity. Management of PAS requires coordinated cesarean hysterectomy. Associated morbidities include blood transfusion, coagulopathy, and intensive care unit (ICU) admission. Accurate prediction of ICU admission allows for enhanced multidisciplinary management, coordination of care and utilization of resources. Scoring systems exist in other surgical specialties that can predict the likelihood of ICU admission, but these have not been applied to an obstetric population. The SAS is a 10-point scale that has been validated for the prediction of ICU-level care requirements within 72 h post-operatively in numerous surgical specialties. The purpose of this study was to apply the Surgical APGAR Score (SAS, version 9) to patients undergoing management of PAS to determine if it can predict ICU admission in this population. Materials and Methods: This is a case–control study. We retrospectively analyzed 127 cases of pathology-confirmed PAS patients who underwent cesarean hysterectomy in singleton, non-anomalous, viable pregnancies. Our primary outcome was ICU admission. In addition, secondary outcomes included antepartum characteristics, operative time, intraoperative events as well as post-operative complications and total postoperative length of stay. SAS was assigned by extracting estimated blood loss (EBL), and the lowest mean intraoperative heartrate (HR and mean arterial pressure (MAP) from intraoperative documentation. Categorical and continuous factors were summarized using frequencies and percentages or means ± SD or median and range as appropriate. Pearson’s chi-square, Fisher’s exact tests, and Mann–Whitney U and t-tests were applied when appropriate. Logistical regression to assess the impact of SAS on ICU admission was performed. p-values < 0.05 were considered significant for two-tailed analysis. Statistical analysis was performed using Graphpad software (version 9). Results: Fifty-eight patients (45%) were admitted post-operatively to the ICU, while 69 patients (55%) were admitted for routine care to the post-anesthesia care unit. Baseline demographics were similar between groups. Forty-four patients (52%) admitted to the ICU had a SAS score < 4. SAS < 4 was associated with greater blood loss (3000 vs. 2500 mL, p = 0.03) and longer operative time (198 vs. 175 min, p = 0.03). Logistic regression analysis of SAS score and ICU admission revealed a low predictive value (OR 2.28, AUC = 0.599). Conclusions: The SAS system is a poor tool for the prediction of ICU admission in patients with PAS undergoing cesarean hysterectomy. A risk calculator that accounts for the unique physiologic changes in pregnancy and high risk for pregnancy is needed. Full article

Background: Hypertensive disorders of pregnancy (HDP), including gestational hypertension and preeclampsia, affect up to 10% of pregnancies worldwide and remain a leading cause of maternal and perinatal morbidity and mortality. These conditions are associated with adverse fetal outcomes, including preterm birth, growth restriction, and maternal complications such as stroke, eclampsia, multi-organ dysfunction, and a higher risk of long-term cardiovascular complications. Current management relies largely on intermittent blood pressure monitoring and assessment of symptoms, approaches that provide limited insight into the complex hemodynamic alterations underlying HDP. Objective: This narrative review aims to synthesize the available evidence on noninvasive cardiography through thoracic electrical bioimpedance (TEB) as a tool for maternal hemodynamic monitoring in pregnancy, with a focus on hypertensive disorders. Specifically, we (1) describe maternal cardiovascular adaptations in normal gestations and their disruption in HDP, (2) provide an overview of thoracic electrical bioimpedance cardiac output (TEBCO) technology, (3) summarize validation studies in pregnant populations, (4) explore potential clinical applications, including diagnostic support, therapeutic guidance, fluid management and postpartum surveillance, and (5) identify key limitations and research priorities for future practice. Conclusions: Noninvasive cardiography through thoracic electrical bio-impedance is an underutilized tool in the medical field. As an alternative to invasive assessment, TEBCO can identify underlying pathologic hemodynamic changes susceptible to treatment and allow monitoring of hemodynamic trends. The implementation of TEBCO would allow pathophysiologic-based treatments, improve clinical response to therapy, and lead to potential prolongations of pregnancy and cost-savings in healthcare. Current evidence is limited by small sample sizes, device variability, and lack of outcome-based trials. Future research should focus on standardized validation, multicenter studies, and interventional trials to determine whether non-invasive cardiography-guided care can improve maternal and neonatal outcomes. Full article

Background: Systemic inflammatory factors may be altered by periodontitis and/or COVID-19, potentially increasing the risk of adverse pregnancy outcomes, a relationship that remains unclear. Objective: This study aimed to identify associations between periodontitis and COVID-19 during pregnancy, evaluating the influence of dental care on obstetric variables through set theory and probability. Methods: A quantitative, cross-sectional, and correlational study was conducted in two phases. The first phase analyzed 156 medical records from 5 institutions, including gynecological and periodontal data; the second phase examined 104 records from a single institution selected for data completeness (2020–2021). Descriptive statistics, bivariate analysis, chi-square tests, and odds ratios were applied. Set operations (union, intersection) and relative probabilities were calculated using R and Excel. Sets represented dental care, dental disease, COVID-19 diagnosis, gestational age, neonatal weight, and complications. Results: In Phase 1, 37% of pregnant women were COVID-19-positive, 44% vaccinated, 51.9% underwent cesarean section, and 5.12% had periodontitis. In Phase 2, 76 pregnant women did not receive dental care, while 28 did; among them, 6 were COVID-19-positive. Mean neonatal weight ranged from 2336 g (dental care) to 2271 g (no dental care). COVID-19-positive pregnant women showed fewer complications and a higher proportion of normal-weight neonates. Gingivitis was the most frequent periodontal condition (75%). No statistically significant differences were observed between the analyzed sets. Conclusions: no direct relationship was found between periodontitis and neonatal weight in COVID-19-positive cases. Dental care did not influence maternal–fetal outcomes. The methodology provides an innovative framework for clinical analysis through mathematical abstraction. Full article

Background/Objectives: The objective was to establish whether particular SPD risk factors are correlated with particular SPD patterns and whether these factors affect the motor development of children Methods: The study procedures included medical examinations, conducted by a pediatrician/child neurologist, and evaluations, performed by a physiotherapist/sensory integration specialist, which were performed on the study group. Results: The study included 156 Caucasian children with SPD aged 3 to 12 years. The results of this study demonstrate that serological conflict shows correlations with taste, smell, and visual hyposensitivity. Fetal heart rate fluctuations, indicated in CTG, are correlated with tactile hypersensitivity and vestibular hypersensitivity, and cesarean delivery is correlated with auditory hyposensitivity. Incubator care is correlated with tactile hypersensitivity and auditory hyposensitivity. Intrauterine infections are correlated with vestibular hypersensitivity. Delayed motor development is correlated with bed rest in the third trimester of pregnancy, intrauterine infections, and incubator care. Conclusions: We conclude that children’s development must be monitored scrupulously in particular areas of sensory processing with regard to any of the abovementioned risk factors occurring in affected children. It is important to pay special attention to intrauterine infections, bed regimes in the third trimester of pregnancy, and incubator care, because these factors may have a negative impact on motor development. Full article

Background/Objectives: The management of high-risk pregnancies remains a major clinical challenge, particularly regarding the optimal timing of delivery, which has significant implications for both perinatal outcomes and healthcare costs. In this context, computerized cardiotocography (cCTG) offers an objective, non-invasive and cost-effective method for fetal surveillance, providing quantitative measures of heart rate dynamics that reflect autonomic regulation and oxygenation status. This study aimed to develop and validate regression-based machine learning models capable of predicting the duration of neonatal hospitalization—an objective and quantifiable indicator of neonatal well-being—using cCTG parameters obtained outside of labor, binary clinical variables describing the presence or absence of pregnancy pathologies, and gestational age at monitoring and at delivery. Methods: A total of 694 singleton high-risk pregnancies complicated by gestational diabetes, preexisting diabetes, intrahepatic cholestasis of pregnancy, pregnancy-induced or preexisting hypertension, or fetal growth restriction were enrolled. Twenty clinically relevant features derived from cCTG recordings and perinatal data were used to train and evaluate four regression algorithms: Random Forest, CatBoost, XGBoost, and LightGBM against a linear regression model with Ridge regularization serving as a benchmark. Results: Random Forest achieved the highest generalization performance (test R² = 0.8226; RMSE = 3.41 days; MAE = 2.02 days), outperforming CatBoost (R² = 0.7059), XGBoost (R² = 0.6911), LightGBM (R² = 0.6851) and the linear regression benchmark with Ridge regularization (R² = 0.5699) while showing a consistent train–validation–test profile (0.9428 → 0.8042 → 0.8226). The error magnitude (≈2 days on average) is clinically interpretable for neonatal resource planning, supporting the model’s practical utility. These findings justify selecting Random Forest as the final predictor and its integration into a clinician-facing application for real-time length-of-stay estimation. Conclusions: Machine learning models integrating cCTG features with maternal clinical factors can accurately predict neonatal hospitalization duration in pregnancies complicated by maternal or fetal disease. This approach provides a clinically interpretable and non-invasive decision support tool that may enhance delivery planning, optimize neonatal resource allocation, and improve perinatal care outcomes. Full article

Background: Cardiovascular disease (CVD) in pregnancy is a major cause of maternal morbidity and mortality, accounting for nearly one-third of pregnancy-related deaths worldwide. Physiological adaptations—expanded plasma volume, increased cardiac output, and a prothrombotic state—represent a natural cardiovascular stress test that may precipitate decompensation or unmask subclinical disease. Aim: This review critically examines contemporary evidence and international guidelines on the management of pregnancy-related cardiovascular disorders, focusing on pathophysiological mechanisms, diagnostic challenges, and therapeutic controversies. Content: The discussion centers on three high-impact clinical domains: (1) peripartum and preexisting cardiomyopathies, emphasizing mechanisms, prognosis, and the role of bromocriptine; (2) anticoagulation management in women with mechanical prosthetic valves, balancing maternal safety and fetal protection; and (3) hypertensive disorders of pregnancy, highlighting recent evidence from the CHAP and WILL trials and their implications for long-term cardiovascular prevention. Comparative analysis of ESC 2025 and AHA 2020 recommendations reveals broad consensus but persistent discrepancies in anticoagulation targets, postpartum surveillance, and follow-up strategies. Perspectives: Endothelial dysfunction, angiogenic imbalance, and systemic inflammation emerge as shared mechanisms linking diverse pregnancy-related cardiovascular conditions. Strengthening multidisciplinary care through Pregnancy Heart Teams, integrating obstetric and cardiologic expertise, and establishing structured postpartum follow-up pathways are essential to improve outcomes. Full article

Background/Objectives: Diabetes mellitus (DM) in pregnancy, including type 1 (T1DM), type 2 (T2DM), and gestational DM (GDM), represents an increasing health burden due to its maternal and fetal complications. Despite the increment in the global prevalence estimates of DM in pregnancy, in Romania, it has not been comprehensively described. This study aimed to analyze the prevalence and dynamics of DM in pregnancy in Romania between 2014 and 2024, using national databases, and to identify prevention strategies for reducing maternal and fetal complications. Methods: Data were obtained from the Romanian National Public Health Institute through two distinct sources: Database 1, consisting of reports from public and medical units associated with the National Health Insurance House and Database 2, based on the reports from general practitioners. Pregnancies complicated by DM were assessed by type, age group, and environmental settlement. Additional data were extracted on pregnancies with insufficient prenatal care and those of socially vulnerable individuals. Results: From 2014 to 2024, the prevalence of DM in pregnancy in Romania was consistently lower than European and global estimates, ranging from 1.01‰ to 3.08‰ in Database 1 and from 0.84‰ to 5.88‰ in Database 2, respectively. GDM accounted for the majority of cases, accounting for 65–88% of reported DM in pregnancy. The highest incidence was observed in the 20–39 years age group, with a growing proportion in women aged ≥40 years. Urban-rural disparities decreased over the decade, with rural cases reaching parity by 2024. Vulnerable populations included adolescents, women with insufficient prenatal care, and those with social risk factors, predominantly from rural areas. Conclusions: Although the reported prevalence of DM in pregnancy in Romania is lower than international figures, the true burden is likely underestimated. GDM remains the leading type of DM in pregnancy, mirroring global trends. Strengthening the reporting system, standardizing diagnostic criteria, and targeting high-risk groups through preconceptional counselling, lifestyle interventions, advanced monitoring technologies, and improving social support through the involved authorities are crucial steps to reduce maternal and fetal morbidity. Full article

Objectives: The aim of our study was to assess the efficacy and safety of two different labor induction methods in patients after fetal demise beyond 28 weeks, with an unfavorable cervix: misoprostol—prostaglandin E1 analog (PGE1) and dinoprostone—prostaglandin E2 analog (PGE2). Methods: This retrospective single-center cohort study included all labor cases after fetal demise (intrauterine fetal death or termination of pregnancy with feticide) from 28 to 40 weeks of gestation, where labor was induced by either PGE1 or PGE2. The primary outcome was the induction-to-delivery time interval. Secondary outcomes included the proportion of patients who delivered within 24 h, the failed induction rate, the length of labor, pain during induction, the adverse outcome rate, and the post-labor hospital stay. Results: The induction-to-delivery time interval was shorter in the PGE1 group (p = 0.048). There was no statistically significant difference in the proportion of patients who delivered within 24 h (p = 0.651) and failed inductions (p = 0.18) between groups. The duration of labor was longer in the PGE2 group (p = 0.01). Oxytocin augmentation was more common in the PGE2 group (p < 0.001). Pain during induction was greater in women in the PGE1 group (p < 0.001). There were no statistically significant differences in adverse effects between groups. There was no significant difference in induction to delivery interval between the two methods when comparing lower and higher gestational ages (28 to 34 weeks, p = 0.18; 35 to 40 weeks, p = 0.343). Conclusions: Our findings support the use of a PGE1 regimen for third-trimester labor induction after fetal demise, when no contraindications exist. This approach appears to improve the efficiency of induction and may enhance overall patient care by reducing intervention needs. Full article

Background Facial clefts are rare congenital malformations, occurring in approximately 1 in 700 live births for cleft lip and palate and fewer than 1 in 100,000 for atypical Tessier clefts. They pose significant diagnostic and surgical challenges. While genetic, vascular, and environmental factors are well documented, growing embryological evidence suggests that the trigeminal nerve may also contribute to craniofacial development. This narrative review explores the association between trigeminal nerve development and facial clefts, aiming to provide a neurodevelopmental perspective with clinical implications, particularly in the context of personalized medicine, where patient-specific neuroanatomical and developmental factors can guide tailored care. Methods A narrative review of embryological, anatomical, and clinical data was conducted. Histological analyses of malformed fetuses and normal human embryos were integrated with published studies. Clinical findings were compared with Paul Tessier’s facial cleft classification and mapped against trigeminal innervation territories. Results Two groups of facial clefts emerged according to the timing of trigeminal disruption. Early embryonic damage (before 10 weeks of gestation) produces superficial epidermal continuity with fibrotic tissue replacing normal deep structures. Later fetal damage results in complete clefts with full tissue discontinuity. The distribution of these clefts corresponds to trigeminal nerve terminal branch territories, supporting the hypothesis that trigeminal innervation exerts trophic effects on craniofacial morphogenesis through neurohormonal signaling. Conclusions Early impairment of trigeminal development may play a pivotal role in the pathogenesis of certain clefts. The spatial and temporal relationship between nerve development and morphogenesis should be considered in classification and surgical planning. However, limitations of this narrative approach include selective literature coverage and lack of quantitative synthesis. Future directions include single-cell transcriptomics, organoid models, and fetal MRI tractography to clarify trigeminal–mesenchyme interactions and inform therapeutic strategies. These advances may foster a personalized medicine approach, enabling more precise prenatal diagnosis, individualized surgical planning, and optimized long-term outcomes. Full article

Background/Objectives: Pregnant women with Inflammatory Bowel Disease (IBD) require careful management to ensure optimal maternal and fetal outcomes. Whether IBD is a risk factor for pre-eclampsia is controversial. We aimed to investigate the incidence of venous thromboembolism (VTE), pre-eclampsia, and risk of disease flare from low-dose aspirin. Methods: This is a retrospective study of the Leeds combined IBD antenatal clinic providing joint specialist gastroenterology and obstetric consultations from 2015 to 2024. Primary outcomes were incidence of VTE, incidence of pre-eclampsia, and disease flare whilst taking aspirin. Results: In 574 pregnancies a single episode of VTE occurred. Adherence to VTE prophylaxis guidelines was good for post-partum periods but only 2 of 51 cases with third-trimester flare received the required VTE prophylaxis. The incidence of pre-eclampsia in this cohort was low at 2.7%. The majority of women deemed high-risk for pre-eclampsia received prophylaxis with aspirin in accordance with guidelines. The risk of symptomatic disease flare was not increased for aspirin users (21.6% versus 22.2% for non-users (p = 0.61)). Conclusions: The incidence of VTE and pre-eclampsia was low in this cohort of pregnant women with IBD. Pre-eclampsia prophylaxis in adherence to guidelines was good and was not associated with an increased flare risk. VTE prophylaxis for third-trimester flares was insufficient and requires better attention from IBD specialists, who are most likely to encounter patients with IBD flares. Full article

Background: We aimed to compare the perinatal outcomes of dichorionic/diamniotic twin (DC/DA) pregnancies resulting from in vitro fertilization (IVF) with those resulting from spontaneous DC/DA pregnancies. Methods: The study group included 99 women with DC/DA pregnancies resulting from IVF, and the control group included 92 women with spontaneous DC/DA pregnancies. Maternal demographic characteristics (age, parity, and gravidity), pre-existing conditions (chronic hypertension and pregestational diabetes mellitus), and obstetric history were recorded. Pregnancy outcomes included gestational age at delivery, number of fetuses, and mode of delivery. The antepartum complications that we evaluated include first- and second-trimester bleeding, placenta previa, preterm birth, fetal growth restriction (FGR), oligohydramnios, and tocolytic use. The obstetric complications that we assessed include prematurity, twin-to-twin transfusion syndrome (TTTS), and hydrops fetalis. Additionally, neonatal data such as 1st minute and 5th minute Apgar scores, birth weight, neonatal intensive care unit (NICU) admission, presence of congenital anomalies, and neonatal death were recorded, and comparisons were made between the groups. Results: Women in the IVF group were older (34.7 ± 6.9 vs. 32.3 ± 6.1 years, p = 0.03) and more frequently primiparous (73.7% vs. 37.0%, p < 0.001). The mean gestational age at delivery was slightly lower in the IVF group, though this was not statistically significant (34.3 ± 3.5 vs. 35.1 ± 2.5 weeks, p = 0.101). Cesarean delivery was common in both groups, with comparable overall rates (90.9% vs. 94.6%, p = 0.411), but emergency cesarean section occurred more frequently in IVF pregnancies (81.8% vs. 55.8%, p = 0.001). No significant differences were found regarding chronic hypertension or pregestational diabetes. However, several differences were demonstrated in terms of obstetric complications. For example, preterm births and fetal growth restriction (FGR) were significantly more frequent in IVF pregnancies (59.8% vs. 30.4%, p < 0.001), and tocolytic use was also more frequent (56.6% vs. 29.7%, p < 0.001). No significant differences were observed in terms of placenta previa, oligohydramnios, TTTS, hydrops fetalis, and neonatal outcomes. The logistic regression analysis revealed that IVF pregnancies were associated with an increased risk of preterm birth: OR 3.45, 95% CI 1.85–6.78 (p < 0.001); the risk of FGR was also higher in IVF pregnancies: OR 2.11, 95% CI 1.02–4.37 (p = 0.015). However, tocolytic use was not significantly associated with IVF: OR 1.49, 95% CI 0.50–4.44 (p = 0.471). Conclusions: Although DC/DA pregnancies conceived through IVF have a higher risk of preterm birth, fetal growth restriction, and greater use of tocolytic agents than spontaneous DC/DA pregnancies, their neonatal outcomes are similar. Full article

Chikungunya virus (CHIKV) infection during pregnancy represents an increasing public health concern, especially in endemic and epidemic regions. The main concern is vertical transmission, particularly during the peripartum period, which can lead to severe neonatal outcomes such as encephalopathy, hematologic abnormalities, and long-term neurodevelopmental impairment. This review synthesizes current knowledge on pathophysiology, clinical manifestations, diagnosis, maternal and neonatal outcomes, and management of CHIKV infection in pregnancy. Diagnosis relies on clinical evaluation supported by laboratory confirmation, RT-PCR in the acute phase and IgM serology thereafter. Treatment is supportive, using acetaminophen as first-line therapy and corticosteroids for selected refractory cases. No antivirals or vaccines are approved for use in pregnancy as of 2025. Prevention is centered on vector control, personal protection, and epidemiological surveillance. Delivery planning and neonatal monitoring are essential when infection occurs close to term due to the high risk of peripartum transmission. Despite growing recognition of CHIKV’s maternal–fetal impact, significant gaps remain regarding long-term outcomes and optimal management strategies. Strengthening prenatal care, neonatal preparedness, and surveillance systems is crucial to mitigate adverse outcomes and inform future clinical and public health policies. Full article

(1) Background: The assessment of neonatal health and prognosis is one of the most critical areas in pediatric medicine. Intrauterine inflammation and the fetal inflammatory response syndrome (FIRS) are increasingly recognized as major determinants of neonatal morbidity. Interleukin-6 (IL-6), measured in the umbilical cord (UC) blood, has emerged as a promising biomarker, reflecting both intrauterine conditions and early neonatal risk. This narrative review aims to synthesize current evidence on the predictive value of umbilical cord blood IL-6 for neonatal outcome, including sepsis, respiratory distress, hypoxic–ischemic encephalopathy (HIE) and mortality. (2) Methods: A comprehensive literature search was conducted in PubMed, Scopus, and Web of Science. Studies reporting umbilical cord IL-6 levels in relation to neonatal outcomes were analyzed and summarized narratively. (3) Results: Evidence consistently indicates that elevated umbilical cord IL-6 is associated with early-onset neonatal sepsis (EONS) and respiratory complications, and provides prognostic insight into neurological outcomes, even though results are influenced by gestational age (GA), mode of delivery, and the presence of chorioamnionitis. (4) Conclusions: UC IL-6 represents a valuable early biomarker for neonatal risk stratification and supports clinical decision-making. Future research should prioritize assay standardization, reference interval development, and prospective multicenter studies to validate its integration into routine neonatal care. Full article

Depression is a common mental disorder during gestation, posing potential risks to fetal development and leading to behavioral and psychiatric alterations in offspring. Pharmacological intervention, particularly with selective serotonin reuptake inhibitors (SSRIs), is often necessary. This study investigated the effects of fluoxetine (F) on behavioral and memory changes in rodent offspring following maternal gestational and lactation treatment, as well as potential alterations in hippocampal cellularity compared to control (C) progeny. Methodologies included the Morris water maze, elevated plus maze, activity monitoring, parental behavior assessments, and isotropic fractionation for the quantification of hippocampal cells and neurons. Results indicated that maternal fluoxetine exposure significantly affected the body mass, brain weight, and hippocampal metrics of the offspring, aligning with the ‘selfish brain’ hypothesis. Notably, dams treated with fluoxetine showed reduced parental care, leading to offspring with increased activity levels but no changes in anxiety-like behaviors. However, while there was a decline in learning and memory retention, as assessed by the Morris water maze, working and reference memory did not differ significantly from those of controls. This study establishes an association between fluoxetine treatment, increased hippocampal neuron density, and behavioral changes related to memory and hyperactivity, with implications for understanding behavioral disorders and informing future therapeutic interventions. Full article

Background/Objectives: There is a paucity of research studying point-of-care ultrasound in the pregnant population, despite the rising incidence of maternal medical complications and, in particular, preeclampsia. This study sought to compare the inferior vena cava collapsibility index (IVC-CI) between patients with preeclampsia with severe features (PECS) and gestational age-matched controls and to assess whether pulse pressure (PP) correlates with IVC-CI in PECS. Methods: This was a prospective pilot study of patients recruited at an inpatient hospital and an outpatient office. The case group included admitted patients with a diagnosis of PECS considered to be stable for prolonged antepartum expectant management. One patient per gestational age week from 23 to 34 weeks with PECS was compared to a gestational age-matched patient without any form of preeclampsia and/or gestational hypertension. Patients on magnesium sulfate, those with multiple gestation, large-for-gestational age fetus, fetal growth restriction, polyhydramnios, oligohydramnios, and/or an anomalous fetus were excluded. Results: IVC-CI was significantly lower in the PECS group compared with controls (mean 20.1% vs. 48.3%, 95% CI = −0.40–−0.16, p < 0.001). There was an inverse relationship between IVC-CI and pulse pressure in patients with PECS. For each additional 1 mmHg in pulse pressure, the odds of having IVC-CI greater than 50% decreased by 13%. Conclusions: Patients with preeclampsia exhibit detectable changes in inferior vena cava diameter that can be assessed with bedside ultrasound and correlated with maternal PP. Future research should focus on validating these findings and exploring the clinical significance of these measurements. Full article